Document is current

Any future updates will be listed below

Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular risk

Crossref DOI link: https://doi.org/10.1007/s00198-024-07347-3

Published Online: 2025-01-08

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark